A company still losing money with growing sales, with elevated risk. Institutions are adding.
Facts from SEC filings, not a recommendation.
Last 12 months: $154.3M, up 275% from the 12 months before.
Price chart by TradingView.
From annual reports filed with the SEC. Not in this company's SEC data, so not scored: return on equity 15%+, profitable every year, share count not growing, gross margin 40%+. A checklist is a starting point for research, not a verdict.
No open-market insider buys or sells in the last 90 days.
No trades to chart yet.
SEC filings of any kind. 50 means a normal week.
Institutions added 128.7% to their holdings. 12 bought, 11 sold. 3 quarters of net buying in a row.
No open-market buys or sells in 90 days. Grants and option exercises are left out.
"Owns after" is the insider's holding right after the trade. Pre-planned (10b5-1) sales are set up months ahead, a weaker signal.
57,000 shares at $3.33 avg ($3.23 to $3.55) · $190K
25,000 shares at $3.45 · $86K
50,000 shares at $3.34 · $167K
29,000 shares at $3.16 avg ($3.03 to $3.25) · $92K
7,000 shares at $3.09 avg ($3.06 to $3.12) · $22K
3,000 shares at $3.41 · $10K
Source: SEC EDGAR filings. For informational purposes. Not investment advice.
Report a problem with this page